Salute e Benessere
INAUGURAL LEVERAGED FINANCE FIGHTS MELANOMA LONDON RAISES £1.4 MILLION BENEFITING THE MELANOMA RESEARCH ALLIANCE
"The £1.4M raised by LFFM London will have a transformative impact on our mission," said Stephanie Kauffman , president of the Melanoma Research Alliance. "This generous support allows us to continue our investments in brilliant UK-based researchers providing them with crucial resources they need to push the boundaries of melanoma research, driving forward innovations that bring us closer to a cure and improve patient outcomes in the UK and around the world."
LFFM was founded in 2011 by (Veritas Capital) and (General Atlantic Credit), who were both diagnosed with melanoma. Since then, it has raised more than £22 million to support MRA's ambitious melanoma research agenda.
The event was co-chaired by (Apax Partners), (Apollo), (General Atlantic), (Fitch), and (Golub Capital).
The event host committee included: HPS), (Kirkland & Ellis), (Hg Capital), Blackstone Credit ), CIFC), Inflexion), CVC Credit), (White & Case), HPS), KKR Capital Markets), UBS), (Termgrid), Paul Weiss ), Carlyle), Sona), (Latham & Watkins), (London Stock Exchange Group) and PSP Investments.
The evening was sponsored by industry leading giants with Global LFFM Partners including .
Platinum sponsors included , and
Gold Sponsors included and
Preferred Sponsors included and
Advocate Sponsors included and
The Melanoma Research Alliance (MRA) stands as the largest non-profit, non-governmental funder of melanoma research. Founded in 2007 by Debra and Leon Black , MRA's mission is to end suffering and death due to melanoma by advancing the world's most promising science and research. MRA provides critical funding for melanoma cancer research that propels advances in prevention, diagnosis, treatment, metastasis, and survivorship. MRA-funded researchers have been behind every major melanoma research breakthrough. Since MRA's inception, more than 17 new therapeutic approaches for melanoma have earned FDA (Food and Drug Administration) approval. MRA is recognized as one of the most fiscally efficient non-profits in the world. Because the Black Family generously underwrites 100% of MRA's administrative and operating costs, every dollar donated is invested directly into MRA's scientific and research program. For more information, please visit: www.CureMelanoma.org.
KWT Global
mra@kwtglobal.com
Dana Deighton , MRA Director, Communications & Engagement
ddeighton@curemelanoma.org
Photo - https://mma.prnewswire.com/media/2611851/Picture1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/inaugural-leveraged-finance-fights-melanoma-london-raises-1-4-million-benefiting-the-melanoma-research-alliance-302366863.html